Preparation and drug release behavior of temperature-responsive mesoporous carbons

A temperature-responsive composite based on poly (N-isopropylacrylamide) (PNIPAAm) and ordered mesoporous carbons (OMCs) has been successfully prepared by a simple wetness impregnation technique. The structures and properties of the composite were characterized by infrared spectroscopy (IR), X-ray diffraction (XRD), transmission electron microscopy (TEM), N₂ sorption, thermogravimetric analysis (TG) and differential scanning calorimetry (DSC). The results showed that the inclusion of PNIPAAm had not greatly changed the basic ordered pore structure of the OMCs. Ibuprofen (IBU) was selected as model drug, and in vitro test of IBU release exhibited a temperature-responsive controlled release delivery.     

Templated Synthesis of Ordered Mesoporous Carbons with Tailored Structures and Morphologies

Due to the excellent biocompatibility and the capability to load and release drugs, ordered mesoporous carbons (OMCs) have been highly prospective and valuable in drug delivery system. In this contribution, synthesis of OMCs with tailored pore sizes from 4.1 to 3.4 nm was achieved by employing SBA‐15 as template and furfuryl alcohol (FA) as carbon precursors. An array of OMCs with controlled structures and morphologies by incipient wetness with FA was analyzed by powder X‐ray diffraction (XRD), nitrogen adsorption, transmission electron microscopy (TEM), and Raman spectroscopy. The resulting carbon replicas retained the hexagonal symmetry of the silica templates SBA‐15 with p6mm space group, although the framework suffered shrinkage in the replicated process. The pore size distribution, uniformity and pore volume of the mesopores in the OMCs were affected by structural properties of the SBA‐15 templates as shown by N₂ sorption and XRD pattern analysis. The process had the advantage that the textural parameters of the obtained OMCs were tunable simply by varying aging temperature of the silica template and the ratio of carbon precursor.     

核-隔层-壳结构Fe3O4@MoO3@mSiO2纳米载体的合成及其药物可控释放

利用加热均匀、迅速、热平稳性好和安全性高的微波热响应来实现药物的微波可控释放。引入具有微波热响应性质、热稳定性和化学稳定性好的Mo O3作为微波吸收物质,制备了核-隔层-壳结构Fe_3O_4@MoO_3@mSiO_2纳米药物载体。研究该纳米载体对药物布洛芬(IBU)的负载和微波响应可控释放过程。该纳米载体具有高的比表面积(222 cm2·g-1)和较大的孔隙体积(0.14 cm3·g-1)可用来负载药物。同时还具有较好的磁响应性,可实现药物的靶向给药,具有相对好的微波热响应性,可通过MoO_3中间层吸收微波辐射实现药物的可控释放。结果表明,在持续微波辐射360 min时IBU的释放率达到86%,远远高于仅搅拌时的释放率。     

核-隔层-壳结构Fe3O4@MoO3@mSiO2纳米载体的合成及其药物可控释放

利用加热均匀、迅速、热平稳性好和安全性高的微波热响应来实现药物的微波可控释放。引入具有微波热响应性质、热稳定性和化学稳定性好的MoO₃作为微波吸收物质,制备了核-隔层-壳结构Fe₃O₄@MoO₃@mSiO₂纳米药物载体。研究该纳米载体对药物布洛芬（IBU）的负载和微波响应可控释放过程。该纳米载体具有高的比表面积（222 cm²·g^-1）和较大的孔隙体积（0.14 cm³· g^-1）可用来负载药物。同时还具有较好的磁响应性,可实现药物的靶向给药,具有相对好的微波热响应性,可通过MoO₃中间层吸收微波辐射实现药物的可控释放。结果表明,在持续微波辐射360 min时IBU的释放率达到86%,远远高于仅搅拌时的释放率。     

Fe3O4@mMoO3介孔多功能纳米载体的制备及其微波响应药物传递

以氨基功能化的Fe_3O_4纳米颗粒为磁核,结合直接沉淀法和模板法在其表面包覆上介孔MoO_3层,制备磁性-微波热转换性-介孔结构于一体的多功能核-壳结构复合纳米载体Fe_3O_4@mMoO_3,并对其结构、载药及微波控制靶向给药性进行研究。TEM图表明所得的复合纳米载体具有明显的核壳结构,完美的球形,且壳层中有清晰的孔状结构。磁性和微波热转换特性分析表明,该复合载体兼具良好的磁性和微波热转换特性,可实现药物的靶向可控给药。以布洛芬(IBU)为模型药物,对该复合纳米载体的药物负载能力和微波响应可控释放性进行研究,结果表明,在持续微波辐射90 s时IBU的释放率达到90%,远远高于仅搅拌时的释放率。     

Chemical synthesis of MnFe2O4/chitosan nanocomposites for controlled release of ofloxacin drug

In this study, we synthesized ofloxacin‐loaded MnFe₂O₄ nanoparticles (NPs) surface modified with chitosan (CS‐MnFe₂O₄) for prolonged antibiotic release in a controlled manner. It was found that the synthesized CS‐MnFe₂O₄ was spherical in shape with an average size of 30–50 nm, low aggregation, and good magnetic responsibility. An in vitro drug loading and release kinetics study reveals that the drug delivery system can take 86% of drug load and can release ofloxacin over a sustained period of 3 days. The release kinetics study reveals that the drug follows zero order kinetics and the mechanism of drug release is diffusion‐controlled type. These results indicated that CS‐MnFe₂O₄ NPs with pH‐sensitive properties can be used as candidates for intestinal targeted drug delivery through oral administration by avoiding the drug release in the highly acidic gastric fluid region of the stomach.     

Synthesis of Hydroxyapatite Nanorods under Mild Conditions and Their Drug Release Properties

Hydroxyapatite (HAp) nanorods possess vast potential applications in various fields, and here HAp nanorods with high aspect ratio were synthesized via a convenient two‐stage precipitation‐hydrolysis process at 60°C under atmospheric pressure. The precursor of CaHPO₄ at precipitation stage is well crystallized as nubby morphology with CTAB as surfactant, while CaHPO₄ was dissolved and CTA⁺ stabilized the HAp nuclei during the hydrolysis stage. OH^? ions were absorbed onto the active crystal surface, where Ca²⁺ and PO₄³⁺ reacted with OH^? to make the nuclei grow into larger crystals, and highly crystalline HAp nanorods were obtained by Ostwald ripening. The loaded drug of IBU on the HAp crystals can be 100% released in 24 h. PVP modified HAp nanorods can increase the drug‐loading capacity and release drug faster than pure HAp nanorods. The results indicate that HAp nanorods modified with suitable surfactants are of great use in drug delivery system.     

Influence of Pore Structure on Catalytic Properties of Mesoporous Silica-supported Co-B Amorphous Alloys in Hydrogenation of Cinnamaldehyde to Cinnamyl Alcohol

Co‐B amorphous alloy catalysts supported on three kinds of mesoporous silica (common SiO₂, MCM‐41 and SBA‐15) have been systematically studied focusing on the effect of pore structure on the catalytic properties in liquid‐phase hydrogenation of cinnamaldehyde to cinnamyl alcohol (CMO). Structural characterization of a series of different catalysts was performed by means of N₂ adsorption, X‐ray diffraction, transmission electron microscopy, hydrogen chemisorption, and X‐ray photoelectron spectroscopy. Various characterizations revealed that the pore structure of supports profoundly influenced the particle size, location and dispersion degree of Co‐B amorphous alloys. Co‐B/SBA‐15 was found more active and selective to CMO than either Co‐B/SiO₂ or Co‐B/MCM‐41. The superior catalytic activity could be attributed to the higher active surface area, because most of Co‐B nanoparticles in Co‐B/SBA‐15 were located in the ordered pore channels of SBA‐15 rather than on the external surface as found in Co‐B/SiO₂ and Co‐B/MCM‐41. Meanwhile, the geometrical confinement effect of the ordered mesoporous structure of SBA‐15 was considered to be responsible for the enhanced selectivity to CMO on Co‐B/SBA‐15, inhibiting the further hydrogenation of CMO to hydrocinnamyl alcohol.     

Synthesis of Imatinib‐loaded chitosan‐modified magnetic nanoparticles as an anti‐cancer agent for pH responsive targeted drug delivery

Targeted drug delivery is a promising approach to overcome the limitations of classical chemotherapy. In this respect, Imatinib‐loaded chitosan‐modified magnetic nanoparticles were prepared as a pH sensitive system for targeted delivery of drug to tumor sites by applying a magnetic field. The proposed magnetic nanoparticles were prepared through modification of magnetic Fe₃O₄ nanoparticles with chitosan and Imatinib. The structural, morphological and physicochemical properties of the synthesized nanoparticles were determined by different analytical techniques including energy‐dispersive X‐ray spectroscopy (EDS), field emission scanning electron microscopy (FESEM), Fourier‐transform infrared (FTIR) spectroscopy, high resolution transmission electron microscopy (HR‐TEM), vibrating sample magnetometry (VSM), X‐ray diffraction (XRD) and X‐ray photoelectron spectroscopy (XPS). UV/visible spectrophotometry was used to measure the Imatinib contents. Thermal stability of the prepared particles was investigated and their efficiency of drug loading and release profile were evaluated. The results demonstrated that Fe₃O₄@CS acts as a pH responsive nanocarrier in releasing the loaded Imatinib molecules. Furthermore, the Fe₃O₄@CS/Imatinib nanoparticles displayed cytotoxic effect against MCF‐7 breast cancer cells. Results of this study can provide new insights in the development of pH responsive targeted drug delivery systems to overcome the side effects of conventional chemotherapy.     

Yoctowell Cavities on Magnetic Silica Nanoparticles for pH Stimuli‐Responsive Controlled Release of Drug Molecules

Drug‐delivery systems that medically transport active molecules to diseased cells, in a controlled manner, have gained much attention in recent years. Yoctowell (1 yL=8 nm³ that is, 10^?24 L volume) cavities on magnetic silica nanoparticles were used for the encapsulation and release of the drug molecule, “mitoxantrone ( MTZ )”, and controlled using naturally occurring stimuli, that is, pH. First, MTZ was encapsulated from a bulk solution under physiological conditions, and then released from the yoctowells, in a controlled manner, by manipulating the pH (7.2–3.0). The sustained release of MTZ , the recovery of active yoctowells after the release process and magnetic properties of nanoparticles provide potential for development of a new generation of drug‐delivery system.     

Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system

Luminescence functionalization of the ordered mesoporous SBA-15 silica was realized by depositing a YVO4:Eu3+ phosphor layer on its surface via the Pechini sol-gel process, resulting in the formation of the YVO4:Eu3+@SBA-15 composite material. This material, which combines the mesoporous structure of SBA-15 and the strong red luminescence property of YVO4:Eu3+, can be used as a novel functional drug delivery system. The structure, morphology, porosity, and optical properties of the materials were well characterized by X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy, N2 adsorption, and photoluminescence spectra. As expected, the pore volume, surface area, and pore size of SBA-15 decrease in sequence after deposition of the YVO4:Eu3+ layer and the adsorption of ibuprofen (IBU, drug). The IBU-loaded YVO4:Eu3+@SBA-15 system still shows the red emission of Eu3+ (617 nm, 5D0-7F2) under UV irradiation and the controlled drug release property. Additionally, the emission intensity of Eu3+ increases with an increase in the cumulative released amount of IBU in the system, making the extent of drug release easily identifiable, trackable, and monitorable by the change of luminescence. The system has great potential in the drug delivery and disease therapy fields.     

硬模板法合成磁性石墨化介孔碳及在中药废水吸附处理中的应用

以SBA-15为模板, 蔗糖为碳源, 硝酸铁辅助催化合成磁性石墨化介孔碳复合材料(Fe/GMC). 利用X射线粉末衍射(XRD)、透射电子显微镜(TEM)、N₂吸附-脱附(BET)、拉曼光谱等对反应产物进行了表征. 硝酸铁辅助催化可以在较低碳化温度(900℃)下实现介孔碳的部分石墨化, 并同步生成磁性Fe₃O₄颗粒, 合成的产物比表面积大、孔道有序、磁性强. 运用紫外-可见(UV-Vis)光谱考察了该复合材料对中药红花色素废水的吸附特性,复合材料的吸附速率快、吸附量高, 具有良好的脱色效果并能实现吸附剂的快速固液磁分离.     

Synthesis,characterization and release profiles of nanoparticles self‐assembled from poly (PEGMA‐co‐MMA‐co‐acryloyl‐β‐CD) copolymers

A novel amphiphilic copolymer was synthesized from poly (ethylene glycol) methyl ether methacrylate (PEGMA950), methyl methacrylate (MMA) and acryloyl‐β‐cyclodextrin (acryloyl‐β‐CD) using the composites of (NH₄)₂S₂O₈/NaHSO₃ as the oxidation–reduction initiators. The successful fabrication of poly(PEGMA‐co‐MMA‐co‐acryloyl‐β‐CD) copolymers was confirmed by Fourier transform infrared spectrometer (FTIR), ¹H‐nuclear magnetic resonance (¹H NMR) spectra. The amphiphilic copolymer could self‐assemble into nanoparticles (NPs), and their morphology and particle size distribution were characterized with transmission electron microscopy (TEM), atomic force microscope (AFM) and dynamic light scattering (DLS) methods. Ibuprofen (IBU) was encapsulated in the novel NPs, and the release profiles of IBU were investigated. FTIR and ¹H NMR spectra illustrated that the poly(PEGMA‐co‐MMA‐co‐acryloyl‐β‐CD) copolymers were synthesized without any residual monomers and initiators. TEM and AFM photographs suggested that the obtained NPs were spherical, and the DLS results indicated that the diameter of blank NPs was 157.3 ± 32.7 nm. The IBU release profile showed that the IBU‐loaded NPs had certain pH responsibility. Copyright © 2014 John Wiley & Sons, Ltd.     

Preparation and physicochemical properties of konjac glucomannan ibuprofen ester as a polysaccharide-drug conjugate

Abstract

A novel drug-polysaccharide conjugate with konjac glucomannan (KGM) as a drug carrier was fabricated through the esterification of ibuprofen (IBU), an anti-inflammatory drug, with KGM. The influences of the reaction conditions, such as the amount of ibuprofen acryl chloride, reaction time, reaction temperature, and the amount of catalyst, on the degree of substitution were investigated. KGM ibuprofen ester (KGM-IBU) was characterized by Fourier transform infrared spectrometry (FTIR), X-ray diffraction (XRD), solid-state ¹³C NMR, scanning electron microscopy (SEM), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), and dynamic mechanical analysis (DMA). The hydrophobic structure of IBU in KGM-IBU was proven by the fluorescence emission spectra of pyrene. In addition, by using commercially available ibuprofen sustained-release capsules (IBU-SRC) as a control, the in vitro controlled release performance of KGM-IBU was evaluated. The cumulative release of IBU-SRC within 36?h was 94%, while that of KGM-IBU within 36?h was 77%. The results showed that KGM-IBU had better sustained-release performance without a burst release effect. The obtained products could be used as a potential biocompatible sustained-release drug delivery system.     

Core–Shell Hollow Microspheres of Magnetic Iron Oxide@Amorphous Calcium Phosphate: Synthesis Using Adenosine 5′‐Triphosphate and Application in pH‐Responsive Drug Delivery

Drug nanocarriers with magnetic targeting and pH‐responsive drug‐release behavior are promising for applications in controlled drug delivery. Magnetic iron oxides show excellent magnetism, but their application in drug delivery is limited by low drug‐loading capacity and poor control over drug release. Herein, core–shell hollow microspheres of magnetic iron oxide@amorphous calcium phosphate (MIO@ACP) were prepared and investigated as magnetic, pH‐responsive drug nanocarriers. Hollow microspheres of magnetic iron oxide (HMIOs) were prepared by etching solid MIO microspheres in hydrochloric acid/ethanol solution. After loading a drug into the HMIOs, the drug‐loaded HMIOs were coated with a protective layer of ACP by using adenosine 5′‐triphosphate (ATP) disodium salt (Na₂ATP) as stabilizer, and drug‐loaded core–shell hollow microspheres of MIO@ACP (HMIOs/drug/ACP) were obtained. The as‐prepared HMIOs/drug/ACP drug‐delivery system exhibits superparamagnetism and pH‐responsive drug‐release behavior. In a medium with pH 7.4, drug release was slow, but it was significantly accelerated at pH 4.5 due to dissolution of the ACP shell. Docetaxel‐loaded core–shell hollow microspheres of MIO@ACP exhibited high anticancer activity.     

Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu3+) as a drug carrier

Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu) was successfully synthesized. The obtained MCS: Eu(3+) was performed as a drug delivery carrier to investigate the drug storage/release properties using ibuprofen (IBU) as the model drug. The structural, morphological, textural, and optical properties were well characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), N(2) adsorption/desorption, and photoluminescence (PL) spectra, respectively. The results reveal that the MCS: Eu exhibits the typical ordered characteristics of the mesostructure. This composite shows a sustained release profile with IBU as the model drug. The IBU-loaded samples still present red luminescence of Eu(3+) ((5)D(0)-(7)F(1,2)) under UV irradiation. The emission intensities of Eu(3+) in the drug carrier system vary with the amount of released IBU, making the drug release easily tracked and monitored. The system demonstrates a great potential for drug delivery and disease therapy.     

Iron Metal–Organic Frameworks MIL‐88B and NH2‐MIL‐88B for the Loading and Delivery of the Gasotransmitter Carbon Monoxide

Crystals of MIL‐88B‐Fe and NH₂‐MIL‐88B‐Fe were prepared by a new rapid microwave‐assisted solvothermal method. High‐purity, spindle‐shaped crystals of MIL‐88B‐Fe with a length of about 2 μm and a diameter of 1 μm and needle‐shaped crystals of NH₂‐MIL‐88B‐Fe with a length of about 1.5 μm and a diameter of 300 nm were produced with uniform size and excellent crystallinity. The possibility to reduce the as‐prepared frameworks and the chemical capture of carbon monoxide in these materials was studied by in situ ultrahigh vacuum Fourier‐transform infrared (UHV‐FTIR) spectroscopy and Mössbauer spectroscopy. CO binding occurs to unsaturated coordination sites (CUS). The release of CO from the as‐prepared materials was studied by a myoglobin assay in physiological buffer. The release of CO from crystals of MIL‐88B‐Fe with t_1/2=38 min and from crystals of NH₂‐MIL‐88B‐Fe with t_1/2=76 min were found to be controlled by the degradation of the MIL materials under physiological conditions. These MIL‐88B‐Fe and NH₂‐MIL‐88B‐Fe materials show good biocompatibility and have the potential to be used in pharmacological and therapeutic applications as carriers and delivery vehicles for the gasotransmitter carbon monoxide.     

Calcium Phosphate Nanocarriers Dual‐Loaded with Bovine Serum Albumin and Ibuprofen: Facile Synthesis,Sequential Drug Loading and Sustained Drug Release

A simple and green strategy is reported for the preparation, drug loading, and release properties of a drug delivery system consisting of calcium phosphate (CP) nanocarriers dual‐loaded with bovine serum albumin (BSA) and hydrophobic drug ibuprofen (IBU). The sequential loading of BSA and IBU in calcium phosphate nanocarriers and in vitro simultaneous release of BSA and IBU are realized and investigated. In this method, BSA, which is used as a model protein drug, is encapsulated in situ in calcium phosphate nanocarriers. Subsequently, the typical hydrophobic drug IBU is loaded in the BSA/CP drug delivery system, forming the IBU/BSA/CP dual drug delivery system. The experiments reveal that the preloaded BSA not only reduces the cytotoxicity of calcium phosphate nanocarriers but also significantly improves the IBU drug loading capacity in calcium phosphate nanocarriers and greatly extends the duration of drug release. Thus, the as‐prepared IBU/BSA/CP dual drug delivery system is promising for drug delivery applications.     

Highly Ordered Mesoporous Cobalt Oxide Nanostructures: Synthesis,Characterisation, Magnetic Properties,and Applications for Electrochemical Energy Devices

Highly ordered mesoporous Co₃O₄ nanostructures were prepared using KIT‐6 and SBA‐15 silica as hard templates. The structures were confirmed by small angle X‐ray diffraction, high resolution transmission electron microscopy, and N₂ adsorption–desorption isotherm analysis. Both KIT‐6 cubic and SBA‐15 hexagonal mesoporous Co₃O₄ samples exhibited a low Néel temperature and bulk antiferromagnetic coupling due to geometric confinement of antiferromagnetic order within the nanoparticles. Mesoporous Co₃O₄ electrode materials have demonstrated the high lithium storage capacity of more than 1200 mAh g^?1 with an excellent cycle life. They also exhibited a high specific capacitance of 370 F g^?1 as electrodes in supercapacitors.     

Epoxidation of cyclohexene with H2O2 over efficient water‐tolerant heterogeneous catalysts composed of mono‐substituted phosphotungstic acid on co‐functionalized SBA‐15

A series of Keggin‐type heteropolyacid‐based heterogeneous catalysts (Co‐/Fe‐/Cu‐POM‐octyl‐NH₃‐SBA‐15) were synthesized via immobilized transition metal mono‐ substituted phosphotungstic acids (Co‐/Fe‐/Cu‐POM) on octyl‐amino‐co‐functionalized mesoporous silica SBA‐15 (octyl‐NH₂‐SBA‐15). Characterization results indicated that Co‐/Fe‐/Cu‐POM units were highly dispersed in mesochannels of SBA‐15, and both types of Brønsted and Lewis acid sites existed in Co‐/Fe‐/Cu‐POM‐octyl‐NH₃‐SBA‐15 catalysts. Co‐POM‐octyl‐NH₃‐SBA‐15 catalyst showed excellent catalytic performance in H₂O₂‐mediated cyclohexene epoxidation with 83.8% of cyclohexene conversion, 92.8% of cyclohexene oxide selectivity, and 98/2 of epoxidation/allylic oxidation selectivity. The order of catalytic activity was Co‐POM‐octyl‐NH₃‐SBA‐15 > Fe‐POM‐octyl‐NH₃‐SBA‐15 > Cu‐POM‐octyl‐NH₃‐SBA‐15. In order to obtain insights into the role of ‐octyl moieties during catalysis, an octyl‐free catalyst (Co‐POM‐NH₃‐SBA‐15) was also synthesized. In comparison with Co‐POM‐NH₃‐SBA‐15, Co‐POM‐octyl‐NH₃‐SBA‐15 showed enhanced catalytic properties (viz. activity and selectivity) in cyclohexene epoxidation. Strong chemical bonding between ‐NH₃⁺ anchored on the surface of SBA‐15 and heteropolyanions resulted in excellent stability of Co‐POM‐octyl‐NH₃‐SBA‐15 catalyst, and it could be reused six times without considerable loss of activity.